Childrens Cold Cough Dm Solution
NDC Package 56062-502-26

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Childrens Cold Cough Dm (brompheniramine maleate, dextromethorphan hydrobromide) solution is •do not take more than 6 doses in any 24-hour period•measure only with dosage cup provided•keep dosage cup with product•mL = milliliteragedoseadults and children 12 years over20 mL every 4 hourschildren 6 to under 12 years10 mL every 4 hourschildren under 6 yearsdo not use. This formulation utilizes a solution delivery system. Marketed by Publix Super Markets Inc, this product is identified by NDC 56062-502 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
56062-502-26
Package Description
1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE
Product Code
56062-502
11-Digit Billing Format
56062050226
RxNorm Crosswalk
  • RxCUI: 2683421 - brompheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG in 10 mL Oral Solution
  • RxCUI: 2683421 - brompheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1 MG/ML Oral Solution
  • RxCUI: 2683421 - brompheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG per 10 ML Oral Solution

Clinical Specifications

Proprietary Name
Childrens Cold Cough Dm
Non-Proprietary Name
Brompheniramine Maleate, Dextromethorphan Hydrobromide
Substance Name
Brompheniramine Maleate; Dextromethorphan Hydrobromide
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
•do not take more than 6 doses in any 24-hour period•measure only with dosage cup provided•keep dosage cup with product•mL = milliliteragedoseadults and children 12 years over20 mL every 4 hourschildren 6 to under 12 years10 mL every 4 hourschildren under 6 yearsdo not use

Regulatory & Marketing

Labeler Name
Publix Super Markets Inc
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-28-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 56062-502-26 identifies a specific commercial package of 1 bottle in 1 carton / 118 ml in 1 bottle of Childrens Cold Cough Dm, a human over the counter drug labeled by Publix Super Markets Inc. This solution is formulated for oral use and contains brompheniramine maleate; dextromethorphan hydrobromide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Publix Super Markets Inc on July 28, 2025. The current certification is valid through December 31, 2026.

How is this Publix Super Markets Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 56062050226. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
56062-502-26
11-Digit CMS (5-4-2)
56062-0502-26

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.